Anti-Inflammatory Therapy to Augment CF transmembrane conductance regulator (CFTR) Rescue in Cystic Fibrosis (CF) Patients.
Not yet recruiting
Phase of Trial: Phase 0
Latest Information Update: 11 Apr 2018
At a glance
- Drugs Losartan (Primary)
- Indications Cystic fibrosis
- Focus Proof of concept; Therapeutic Use
- 03 Apr 2018 Planned initiation date changed from 10 Mar 2018 to 10 Jul 2018.
- 22 Feb 2018 New trial record